| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.0044 | 1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |